S-3304 | Interleukin Related interleukin-related.com

Product Name :
S-3304

Search keywords :
S 3304

drugId :
null

Target Vo:
Matrix metalloproteinase 12

Target Vo Short Name :
MMP12

Moa_Name:
Matrix metalloproteinase 9 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Shionogi & Co Ltd

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
14-3-3 eta (YP4052) Mouse mAb Epigenetics
RPS6 (Y10P89) Mouse mAb In stock
CDKN2C Antibody: CDKN2C Antibody is an unconjugated, approximately 15 kDa, rabbit-derived, anti-CDKN2C monoclonal antibody. CDKN2C Antibody can be used for: WB, IHC-P, ICC/IF, IP expriments in background without labeling.

Author: Interleukin Related

Related Posts